Cordes Sabine P
Samuel Lunenfeld Research Institute, Room 865, Mt. Sinai Hospital, Toronto, Ontario M5G 1X5, Canada.
Microbiol Mol Biol Rev. 2005 Sep;69(3):426-39. doi: 10.1128/MMBR.69.3.426-439.2005.
In the mouse, random mutagenesis with N-ethyl-N-nitrosourea (ENU) has been used since the 1970s in forward mutagenesis screens. However, only in the last decade has ENU mutagenesis been harnessed to generate a myriad of new mouse mutations in large-scale genetic screens and focused, smaller efforts. The development of additional genetic tools, such as balancer chromosomes, refinements in genetic mapping strategies, and evolution of specialized assays, has allowed these screens to achieve new levels of sophistication. The impressive productivity of these screens has led to a deluge of mouse mutants that wait to be harnessed. Here the basic large- and small-scale strategies are described, as are the basics of screen design. Finally, and importantly, this review describes the mechanisms by which such mutants may be accessed now and in the future. Thus, this review should serve both as an overview of the power of forward mutagenesis in the mouse and as a resource for those interested in developing their own screens, adding onto existing efforts, or obtaining specific mouse mutants that have already been generated.
自20世纪70年代以来,在小鼠正向诱变筛选中就一直使用N-乙基-N-亚硝基脲(ENU)进行随机诱变。然而,直到最近十年,ENU诱变才被用于在大规模遗传筛选以及更集中、规模较小的研究中产生大量新的小鼠突变。诸如平衡染色体等其他遗传工具的开发、遗传图谱策略的改进以及专门检测方法的发展,使得这些筛选达到了新的复杂程度。这些筛选令人印象深刻的产出导致了大量等待被利用的小鼠突变体。本文描述了基本的大规模和小规模策略以及筛选设计的基础。最后,也是重要的一点,本综述描述了现在及未来获取此类突变体的机制。因此,本综述既应作为对小鼠正向诱变作用的概述,也应作为对那些有兴趣开展自己的筛选、在现有研究基础上进行补充或获取已产生的特定小鼠突变体的人员的参考资源。